LNAILunai Bioworks Inc. Common Stock
2.155USD-2.93%Mkt Cap: 9.77M $P/E: —3d ago
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and …